Jerome Wong - Jun 17, 2022 Form 3 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
Interim CFO
Signature
/s/ Jerome Wong
Stock symbol
EKSO
Transactions as of
Jun 17, 2022
Transactions value $
$0
Form type
3
Date filed
6/22/2022, 05:13 PM
Next filing
Jul 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EKSO Common Stock 20.6K Jun 17, 2022 Direct F1
holding EKSO Common Stock 3.21K Jun 17, 2022 By 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EKSO Stock Option (right to buy) Jun 17, 2022 Common Stock 2.33K $17.85 Direct F2
holding EKSO Stock Option (right to buy) Jun 17, 2022 Common Stock 3K $26.39 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 19,250 time-based Restricted Stock Units ("RSUs") granted under the Company's Amended and Restated 2014 Equity Incentive Plan, as follows: i) 15,000 RSUs that were granted to the Reporting Person on August 1, 2021, 1/3 of which will vest on each of August 1, 2022, 2023 and 2024; ii) 4000 RSUs that were granted to the Reporting Person on November 6, 2019, 1/2 of which will vest on each of November 6, 2022 and 2023; and iii) 250 RSUs that were granted to the Reporting Person on July 13, 2018 and which will vest on July 13, 2022, in each case subject to the Reporting Person's continuous service with the issuer as of each vesting date. Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
F2 The option agreement provides that 1/4 of the option became exercisable beginning on the first anniversary of the option's grant date, and 1/36 vested in equal monthly installments thereafter. The option was granted on August 28, 2017.
F3 The option agreement provides that 1/4 of the option became exercisable beginning on the first anniversary of the option's grant date, with 1/36 vesting in equal monthly installments thereafter. The option was granted on July 13, 2018.

Remarks:

Exhibit 24.1 Power of Attorney